Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kalia

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Lancet (London, England)|February 7, 2025
First phase 3 trial of GLP-1 receptor agonist for neurodegenerationLorraine V Kalia
Parkinsonism & Related Disorders|November 16, 2019
Expert comment: "A case of missing pathology in a patient with LRRK2 Parkinson's disease"Lorraine V Kalia
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 28, 2003
Barriers to women clinician-scientists: a trainee's perspectiveLorraine V Kalia
The Lancet. Neurology|December 13, 2025
Exploring immunomodulation with azathioprine in Parkinson's diseaseLorraine V Kalia
Nature Reviews. Neurology|September 23, 2022
First trials test targeting of α-synuclein for Parkinson diseaseLorraine V Kalia
Parkinsonism & Related Disorders|August 8, 2017
Biomarkers for cognitive dysfunction in Parkinson's diseaseLorraine V Kalia
Parkinsonism & Related Disorders|November 24, 2018
Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluidLorraine V Kalia
Journal of the Indian Society of Pedodontics and Preventive Dentistry|April 15, 2008
Greenstick fracture of the mandible: a case reportV Kalia, A P Singh
Molecular Neurodegeneration|April 28, 2026
LRRK2 and GBA1 in Lewy body diseases: neuropathological subtypes at opposite ends of a spectrum?Vedika Jha, Lorraine V Kalia
Current Opinion in Neurology|June 26, 2015
α-Synuclein and Lewy pathology in Parkinson's diseaseLorraine V Kalia, Suneil K Kalia
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|February 7, 2025
First phase 3 trial of GLP-1 receptor agonist for neurodegenerationLorraine V Kalia
Parkinsonism & Related Disorders|November 16, 2019
Expert comment: "A case of missing pathology in a patient with LRRK2 Parkinson's disease"Lorraine V Kalia
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|March 28, 2003
Barriers to women clinician-scientists: a trainee's perspectiveLorraine V Kalia
The Lancet. Neurology|December 13, 2025
Exploring immunomodulation with azathioprine in Parkinson's diseaseLorraine V Kalia
Nature Reviews. Neurology|September 23, 2022
First trials test targeting of α-synuclein for Parkinson diseaseLorraine V Kalia
Parkinsonism & Related Disorders|August 8, 2017
Biomarkers for cognitive dysfunction in Parkinson's diseaseLorraine V Kalia
Parkinsonism & Related Disorders|November 24, 2018
Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluidLorraine V Kalia
Journal of the Indian Society of Pedodontics and Preventive Dentistry|April 15, 2008
Greenstick fracture of the mandible: a case reportV Kalia, A P Singh
Molecular Neurodegeneration|April 28, 2026
LRRK2 and GBA1 in Lewy body diseases: neuropathological subtypes at opposite ends of a spectrum?Vedika Jha, Lorraine V Kalia
Current Opinion in Neurology|June 26, 2015
α-Synuclein and Lewy pathology in Parkinson's diseaseLorraine V Kalia, Suneil K Kalia
Pageof 15